Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Sherry Unabia
CONTACT
Lead
LTZ Therapeutics, Inc.
LTZ-301 is a bispecific antibody which is a Myeloid cell engager, which targets B-cells via CD79B, and triggers phagocytosis
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
